SlideShare une entreprise Scribd logo
1  sur  43
Télécharger pour lire hors ligne
Dr. Shahnawaz Alam
Resident; MCh-
Neurosurgery
Moderated by:
Dr. V. C. Jha
HOD, Dept. of Neurosurgery
TRIGEMINAL NEURALGIA
DEFINITION, DDX, MANAGEMENT, SURGERY AND GKRS
INTRODUCTION
• Recurrent brief episodes of unilateral electric shock like pains, abrupt in onset
and termination, in the distribution of one or more divisions of the trigeminal
nerve that are typically triggered by innocuous stimuli.
• Incidence: 40-50 cases per million; Prevalence: 100-200 cases per million (1)
• Age group: 35-65 years (2); Right side more commonly affected; Gender: twice
as common in females
• Hereditary forms of TGN rare (<5%); B/l TGN have higher hereditary
predisposition
{1} 1. Manzoni G, Torelli P. Epidemiology of typical and atypical craniofacial neuralgias. Neurological Sciences. 2005;26(S2):s65-s67.
{2} Koopman J, Dieleman J, Huygen F, de Mos M, Martin C, Sturkenboom M. Incidence of facial pain in the general population. Pain. 2009;147(1):122-127.
Diagnosis of typical trigeminal neuralgia: five criteria
1. paroxysmal sharp and shooting pain that is characterized by exacerbations
and remissions,
2. pain that follows the distribution of the trigeminal nerve,
3. a normal neurologic examination that includes no significant loss of facial
sensation,
4. Magnetic resonance imaging (MRI) of the brain that demonstrates neither
mass lesions nor demyelinating plaques, and
5. pain that is induced by cutaneous stimulation.
BRIEF HISTORY
• First scientific account: Johannes Laurentius Bausch (1671)
• Synonyms: Suicide disease, Prosopalgia , Tic Douloureux, Fothergill’s
Disease
• 1820 Charles Bell coined Trigeminal Neuralgia
• 1904  Percutaneous alcohol injection by Schloesser
• 1920  Spiller-Frazier technique of selective sectioning of Trigeminal nerve
fibres, Walter Dandy: ‘arterial loop impingement’
• 1940  Bergouinan used antiepileptic in TGN
• 1970 Leksell used stereotactic radiation
• 1996 Peter Janetta: MVD
DEFINITION (ICHD-3, 2018,IHS)
• Recurrent paroxysms of unilateral facial pain in the distribution(s) of one or
more divisions of the trigeminal nerve, with no radiation beyond, and fulfilling
criteria B and C
• A  All the pain characteristics:
• lasting from a fraction of a second to 2 minutes
• severe intensity
• electric shock-like, shooting, stabbing or sharp in quality
• B Precipitated by innocuous stimuli
• C Not better accounted for by another ICHD-3 diagnosis.
CLINICAL FEATURES
• Pain may radiate to another division; Identification of Trigger
• Usually fail to show sensory abnormalities
• In severe cases can evoke contraction of the facial muscles of the affected side
• Mild autonomic symptoms like lacrimation or redness of eye may be present
• Refractory period
TYPES:
a) Classical Type
b) Secondary Type
c) Idiopathic Type
CLASSICAL TGN
• Classical TGN: Demonstration on MRI/Surgery of Neurovascular Compression and
morphological changes
1) Classical TGN:
Purely Paroxysmal pain free between attacks
2) Atypical TGN/Type II TGN:
Concomitant continuous pain between attacks; Atypical- aching, throbbing, burning,
>50% constant pain.
• Morphological changes: Nerve root atrophy (demyelination, neuronal loss,
microvasculature changes)/ displacement.
• Compression by artery more symptomatic than by compression of vein.
SECONDARY TGN
• Secondary TGN : An underlying disease known to cause neuralgia
1)TGN attributed to MS
2)TGN attributed to SOL
3)TGN attributed to other casues
IDIOPATHIC TGN
• Idiopathic TGN: MRI or electrophysiologic testing showing no abnormalities
• IASP definition: “unilateral painful orofacial condition characterized by brief
duration of electric shock-like sensation with an abrupt onset and termination,
and limited to one or more sensory divisions of the trigeminal nerve”
AETIOLOGY
DIRECT COMPRESSION OF TRIGEMINAL NERVE
• Neurovascular Compression : (80-90% cases)
Vascular Loop; SCA(85%)> AICA > PICA > VA
Venous loop
• MC site: Dorsal Root Entry Zone near Pons
Laminar Arrangement of fibres in Trigeminal nerve
(Medial V2 ,Lateral/caudal V3 , rarely Cranial 
V1 symptoms)
• Tumours(2%) : Meningioma/Vestibular
Schwannoma/epidermoid/Tuberculoma/Arachnoid Cyst
{Tumours at REZ cause neuralgia, peripheral
compression causes more constant pain}
• AVM/Aneurysms
SYSTEMIC DISEASES
• Multiple Sclerosis In 0.9-4.5% patients of MS; young, Bilateral presentation
MR: demyelinating lesion at pontine REZ
• Vascular diseases, Rheumatism, Diabetes, HTN no proven role
• TGN association with atherosclerosis/Arterial hypertonia
• Following previous surgery; Allergic Hypothesis
• TM joint pathology, high position of petrous apex, acute bony angle of
petrous ridge, short trigeminal nerve cisternal length.
PATHOPHYSIOLOGY
• REZ/Redlich-Obersteiner’s Zone:
boundary b/w CNS and PNS
junction between myelin of Schwann and
glial cells
• Visually identified as 1-2.5 mm Zone;
Thin A delta nociceptive fibres are highly
susceptible to pressure
• Long standing compression: membrane
instability and demyelination
interconnection between neurones
• Nerve deviation/distortion: groove
formation nerve atrophy
{Atrophic changes in proportion to
severity of compression}
PATHOGENESIS
• Short Connection Theory: demyelination and cross talk
(Pressure on highly susceptible A delta fibres; ectopic impulse generation;
abnormal non synaptic transmission.
• Ignition Hypothesis: Trigeminal root ganglia neuronal abnormalities
hyperexcitability of neurones and synchronous firing
• Pulsatile mechanical compression by vessel
• Cutaneous stimuli stimulate pain fibres which are in close proximity at REZ
• Focal demyelination not always present
• Central Pathogenetic Mechanism
DIFFERENTIAL DIAGNOSIS
• Deafferentation pain: post surgical injury/trauma {constant itching or burning
pain , sensory loss}
• Dental causes: caries, abscess, periodontitits, cracked tooth
unilateral and localised pain, usually constant, oral mucosal examination for
causes.
• Temporo-Mandibular Joint Disorders  restricted mouth opening or cracking
noises. on prolonged mouth opening, palpation of joint and local examination
• Salivary Gland Disorders  obstruction of flow of saliva :intermittent
pain(tumors, stones) ; infection
• Maxillary sinusitis Acute sinusitis, nasal discharge,tenderness, dull mild to
moderate pain
TRIGEMINAL AUTONOMIC
CEPHALALGIAS
• Primary headache disorders with cranial autonomic symptoms and pain in
Trigeminal nerve distribution.
• Cluster Headache, Paroxysmal Hemicranias, SUNCT, SUNA
• Cluster headache: temporal association with sleep (episodic, u/l typically
periorbital, prolonged course of 15-180 mins, severe throbbing type,
conjunctival injection).
• SUNCT/SUNA : paroxysmal ocular or periocular pain with ipsilateral
autonomic symptoms intense: Conjunctival injection, lacrimation, nasal
congestion, rhinorrhoea, sweating and flushing of forehead
• More common in V1 and least in V3
Difference between TGN and SUNCT/SUNA
DIFFERENTIAL DIAGNOSES
• Post-Herpetic Neuralgia : Usually months after resolution of Herpes
Zoster; Dermatomal Vesicopapular Rash; Allodynia, burning sharp pain;
Sensory loss to pinprick, temperature in affected areas; Continuous pain with
fluctuating severity
• Glossopharyngeal neuralgia: pain in throat- ear areas inferior to angle of
mandible, precipitated by swallowing, chewing
• Nervus Intermedius neuralgia - brief paroxysmal pain in ear canal
• Hemifacial spasm/ Tolosa Hunt syndrome/ Migraine
• Perineural spread of head and neck malignancies
RED FLAG SIGNS IN CLINICAL
EXAMINATION FOR SECONDARY
AETIOLOGIES
 Sensory or motor deficits in cranial nerve examination
 Abnormal oral, dental, or ear examination
 Age younger than 40 years
 Presence of bilateral symptoms
 Dizziness or vertigo
 Hearing loss or abnormality
 Pain episodes persisting longer than two minutes
 Pain outside of trigeminal nerve distribution
 Severe Autonomic symptoms
MRI
• Obersteiner Redlich zone: 1mm for motor root and 3 mm for sensory root
• Visual inspection: thinning of trigeminal myelin sheath
• Ventrolateral pons: two different roots
• Gasserian ganglion
MANAGEMENT
CLINICAL DIAGNOSIS
OF TGN
PHARMACOLOGIC
THERAPY WITH
CBZ/OXZ
DOSE ESCALATION
AND ADDITION OF
2nd/3rd LINE DRUGS
PHARMACORESISTANT
TGN
MRI AND OTHER
SIGNS
NERUOVASCULAR
CONFLICT +
ASA I OR AGE < 75
yrs
MVD
ASA II OR AGE >
75yrs
NEUROVASCULAR
CONFLICT -
SRS, PERCUTANEOUS
PROCEDURES,
NEUROMODULATIVE
PROCEDURES
SECONDARY CAUSES
UNDERLYING CAUSE
TREATMENT
TREATMENT MODALITIES
AVAILABLE
PHARMACOTHERAPY
• First line: CARBAMAZEPINE (Level A evidence)
DOSE: 100 to 200 mg twice daily and increase in 200 mg daily dose as
tolerated upto 600-800 mg daily and maximum of 1200 mg daily; Sodium
channel blockade and membrane stabilisation; Efficacy: 80% pain relief
• HLA-B 1502 individuals higher incidence of Steven Johnson syndrome and
TEN, CBC, Sodium and LFT monitoring; CYP 450 system and failure of
OCPs; 6 to 10% patients are unable to tolerate.
• Oxcarbamazepine: Similar efficacy to CBZ; Pro-drug; Better Tolerability
and fewer drug interactions; Weak enzyme inducer; Dose: 150 mg BD 
increased 300 mg every 3 days to 300-600mg and maximum of 1800 mg.
• 2nd line Drugs :Lamotrigine, Baclofen, Pimozide
SECOND LINE DRUGS
• LAMOTRIGINE: Superior to placebo in CBZ refractory cases; starting dose at
25 mg/day to 200-400 mg/day gradually; slower titration gives slower occurance
of side effects.
• BACLOFEN : GABAb receptor antagomist; dose of 5-10mg TDS and
increased slowly upto a maximum; dose of 90mg per day; Renal excreted drug
• Pimozide :Extrapyramidal side effects; Gabapentin, Pregabalin  moderate
efficacy.
• Phenytoin(60% pain relief); Topiramate(75% pain relief); Levetiracetam(50%
pain relief); TCA: No role in TGN; Quality of evidence poor.
• ACUTE EXACERBATION TREATMENT: initially used local anasthetic and
iv lidocaine; Insufficient evidence and not recommended; Treatment duration:
No definitive evidence of duration of treatment to conclude failure of first line
drugs and indication for surgery
SURGICAL MODALITIES
• Percutaneous: Glycerol Retrogasserian Rhizolysis; Radiofrequency
Thermocoagulation; Percutaneous Microballon Compression.
• Invasive surgery: Microvascular Decompression; Partial sensory Rhizotomy;
Internal Neurolysis; Cryotherapy
• Ablative vs Nonablative procedures.
Trigeminal neuralgia
Trigeminal neuralgia
Trigeminal neuralgia
Trigeminal neuralgia
When to refer for Surgery?
No specific conclusion; 70% patients who failed primary therapy wished
earlier surgery
Failure of first line therapy; ? Second line therapy
Age(old and young) and life expectancy(<20yrs)
Anaesthetic fitness for Surgery; Severity of the Pain
Which Surgical Procedure to choose?
MVD has higher and longer duration of pain control; MVD has 90 % pain
control immediately and 73% at 5 years; Lower chance of hypoesthesia
Peripheral Local anaesthetic techniques not effective.
Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K et al. Practice Parameter: The diagnostic evaluation and treatment of trigeminal
neuralgia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the
European Federation of Neurological Societies. Neurology. 2008;71(15):1183-1190
MICROVASCULAR
DECOMPRESSION
• Long term success rate of 89-100%; More effective in classical TGN with only
paroxysmal attacks
• Acute pain relief in 91% and recurrence of 18%; Initial outcome better than
GKRS.
• Better at initial response and lower recurrence rate than partial sensory
rhizotomy
• MVD and PBC has similar initial pain control but MVD has lower recurrence
rate.
MICROVASCULAR DECOMPRESSION
• Supine position, head rotated and fixed to
opposite side, lateral decubitus position
• Linear retromastoid incision of approx. 3-
5 cm with a fourth above the iniomeatal
line
• Retromastoid Craniotomy made starting at
inferior and posterior to the transverse -
sigmoid junction
• Supralateral Cerebellar approach
 Dura opened in inverted L or C shaped fashion; CSF drained by
gentle retraction of the cerebellum.
 Retraction of cerebellum in Inferomedial direction gently just
below petro-tentorial junction (pure medial retraction = more
injury to CN VIII).
 Exposure of Superior petrosal vein and arachnoid membrane just
inferior to this vessel dissected; Superior petrosal venous bleed
coagulated close to cerebellum.
Trigeminal neuralgia
Trigeminal neuralgia
• Correct Identification of cranial nerves:
7th and 8th complex runs superficially, obliquely
• 5th nerve more medially and deeper; Careful arachnoid
dissection with preservation of BS vessels
• Exposure of Trigeminal nerve REZ.
NEUROVASCULAR CONFLICTS
 Most common by SCA or its branches
along the superior shoulder f REZ
 Combined compression between SCA
and AICA; Between Trigeminal and
petrosal veins; By superior Petrosal
vein.
 Decompression requires elevating the SCA upward
and away from the nerve; Arterial loops dissected
along the length of the nerve; Multiple Vascular
loops.
 Implant: Shredded Teflon; Placed at REZ and
pushed ahead parallel to the nerve; Unshredded
Teflon: more chance of displacement; Materials:
Teflon(Polytetrafluoroethylene), Ivalon(Polyvinyl
acetal).
 Partial sensory root sectioning is indicated in negative vessel explorations during
surgery and large intraneural vein.
 Complications
• MC complication is aseptic meningitis(11%); Cranial nerve damage, Transient
conductive hearing loss.
• SNHL major long term complication (prevented by gentle retraction and prevention of
AICA vasospasm)
• Prolonged post-operative vertigo /tinnitus; CSF rhinorrhoea(4%); Cerebellar
contusions.
GKRS
• First used by Dr Leksell in 1971; Procedure: Leksell stereotactic head frame 
MRI(T1w with or without contrast and T2 CISS sequences)Treatment planning
GKRS.
• Single shot, 4 mm beam collimator diameter; Dose: 70-90 Gy.; Higher dose associated
with higher post irradiation complications but better rates of improvement and lesser
recurrence; Higher required doses placed isocentre anteriorly on TGN away from
brainstem
Target Selection:
Options:
1. REZ close to Brainstem(Pollock et al 90% pain control)
2. Marseille point(distal most portion of cisternal CN V close to Meckels cave) (Regis et al. 87% pain
control)
3. Gasserian ganglion anteriorly(Messenger et al higher sensory complications)
• Pain relief better if isocentre located close to REZ; Less complications if target placed
anteriorly; Anterior targets are likely to have same initial pain control.
AGasserian gangliona; B  Marseille point; C REZ; D Dual Centre
• Gradual response Time to response after GKRS better in anterior
retrogasserian target(median -4.1 weeks) vs REZ targets(median – 6.4 weeks).
• Median latency to symptom improvement- 2 months; Need some
medications(although reduced dosage).
• Freedom from pain with medication(84.8%) vs without medication(53.1%);
Long Term outcome: Good pain control of 45-65% by 5 years.
• Abnormal vessel: Doesn’t alter outcome.
• Redo GKRS: Can be done in patients with an earlier good response to GKRS;
Primary GKRS > Secondary GKRS(in pain relief)
• Pain in V1: GKRS safest option as corneal hyposthesia never occur; No
Radioprotectant role of CBZ/OXZ; Treatment failure if no symptomatic
improvement by 180 days.
• Outcome: 75-90% patients had pain relief after 1 year of GKRS.
Predictors of good pain control:
• Type of Pain at presentation, post GK BNI score, Post GK facial numbness
(major predictor of maintenance of pain relief).
• Patients with early response within 3 weeks had longer duration of complete
free pain.
• Length of Cisternal segment of Trigeminal nerve; Target on Trigeminal nerve
5-8 mm away from brainstem
Favourable outcomes:
• young patient, length of trigeminal nerve irradiated, higher dose of radiation,
proximity of isocentre to Brainstem.
Stereotactic RS yields better response if done within 3 years of symptom
onset.
Poor prognosticator factors: atypical facial pain and presence of MS
 Recurrence rate of TGN post GKRS is 23% at approximately 8 to 20 months
Side effects: facial numbness(more in anterior target or longer length of
nerve irradiated or higher doses),parenchymal injuries, vascular injuries.
References:
• Youmans and Winn neurological surgery 8th edition
• Ramamurthi & Tandon's textbook of neurosurgery 3rd edition
• Schmidek and Sweet: Operative Neurosurgical Techniques 6th edition
• Internet
THANK YOU

Contenu connexe

Tendances

Trigeminal neuralgia
Trigeminal neuralgiaTrigeminal neuralgia
Trigeminal neuralgiaakifab93
 
Application of Neuronavigation in Brain Surgery
Application of Neuronavigation in Brain SurgeryApplication of Neuronavigation in Brain Surgery
Application of Neuronavigation in Brain SurgeryDr Fakir Mohan Sahu
 
Hemifacial spasm
Hemifacial spasmHemifacial spasm
Hemifacial spasmAmr Hassan
 
Principles of craniotomy flaps
Principles of craniotomy flapsPrinciples of craniotomy flaps
Principles of craniotomy flapsAbhishek Rai
 
Clinical anatomy of facial nerve and facial nerve palsy
Clinical anatomy of facial nerve and facial nerve palsy Clinical anatomy of facial nerve and facial nerve palsy
Clinical anatomy of facial nerve and facial nerve palsy Ramesh Parajuli
 
Endoscopic pituitary surgery
Endoscopic pituitary surgeryEndoscopic pituitary surgery
Endoscopic pituitary surgeryAjay Mourya
 
Third ventricular surgical approaches
Third ventricular surgical approachesThird ventricular surgical approaches
Third ventricular surgical approachessuresh Bishokarma
 
CP Angle Tumors (Vestibular Schwannoma)
CP Angle Tumors (Vestibular Schwannoma)CP Angle Tumors (Vestibular Schwannoma)
CP Angle Tumors (Vestibular Schwannoma)yinnshang
 
Jugular foramen anatomy and approaches
Jugular foramen anatomy and approachesJugular foramen anatomy and approaches
Jugular foramen anatomy and approachesDikpal Singh
 
Frontotemporal FTOZ craniotomy
Frontotemporal FTOZ craniotomyFrontotemporal FTOZ craniotomy
Frontotemporal FTOZ craniotomyDr. Shahnawaz Alam
 
Sch 43 surgical management of tumors of the foramen magnum
Sch 43 surgical management of tumors of the foramen magnum Sch 43 surgical management of tumors of the foramen magnum
Sch 43 surgical management of tumors of the foramen magnum Neurosurgery Vajira
 

Tendances (20)

Pterional craniotomy
Pterional craniotomyPterional craniotomy
Pterional craniotomy
 
Trigeminal neuralgia
Trigeminal neuralgiaTrigeminal neuralgia
Trigeminal neuralgia
 
APPROACH TO PINEAL TUMOR
APPROACH TO PINEAL TUMORAPPROACH TO PINEAL TUMOR
APPROACH TO PINEAL TUMOR
 
Application of Neuronavigation in Brain Surgery
Application of Neuronavigation in Brain SurgeryApplication of Neuronavigation in Brain Surgery
Application of Neuronavigation in Brain Surgery
 
Facial nerve palsy & Trigeminal neuralgia
Facial nerve palsy & Trigeminal neuralgiaFacial nerve palsy & Trigeminal neuralgia
Facial nerve palsy & Trigeminal neuralgia
 
Hemifacial spasm
Hemifacial spasmHemifacial spasm
Hemifacial spasm
 
Principles of craniotomy flaps
Principles of craniotomy flapsPrinciples of craniotomy flaps
Principles of craniotomy flaps
 
Clinical anatomy of facial nerve and facial nerve palsy
Clinical anatomy of facial nerve and facial nerve palsy Clinical anatomy of facial nerve and facial nerve palsy
Clinical anatomy of facial nerve and facial nerve palsy
 
Tentorial meningiomas
Tentorial meningiomasTentorial meningiomas
Tentorial meningiomas
 
Endoscopic pituitary surgery
Endoscopic pituitary surgeryEndoscopic pituitary surgery
Endoscopic pituitary surgery
 
Third ventricular surgical approaches
Third ventricular surgical approachesThird ventricular surgical approaches
Third ventricular surgical approaches
 
324 Biomechanical basis of TBI
324 Biomechanical basis of TBI324 Biomechanical basis of TBI
324 Biomechanical basis of TBI
 
Trigeminal Neuralgia
Trigeminal NeuralgiaTrigeminal Neuralgia
Trigeminal Neuralgia
 
Trigeminal Schwannoma.pptx
Trigeminal Schwannoma.pptxTrigeminal Schwannoma.pptx
Trigeminal Schwannoma.pptx
 
Foramen Magnum Meningioma
Foramen Magnum MeningiomaForamen Magnum Meningioma
Foramen Magnum Meningioma
 
CP Angle Tumors (Vestibular Schwannoma)
CP Angle Tumors (Vestibular Schwannoma)CP Angle Tumors (Vestibular Schwannoma)
CP Angle Tumors (Vestibular Schwannoma)
 
10 triangles 360°
10 triangles 360°10 triangles 360°
10 triangles 360°
 
Jugular foramen anatomy and approaches
Jugular foramen anatomy and approachesJugular foramen anatomy and approaches
Jugular foramen anatomy and approaches
 
Frontotemporal FTOZ craniotomy
Frontotemporal FTOZ craniotomyFrontotemporal FTOZ craniotomy
Frontotemporal FTOZ craniotomy
 
Sch 43 surgical management of tumors of the foramen magnum
Sch 43 surgical management of tumors of the foramen magnum Sch 43 surgical management of tumors of the foramen magnum
Sch 43 surgical management of tumors of the foramen magnum
 

Similaire à Trigeminal neuralgia

Trigeminal Neuralgia.pptx
Trigeminal Neuralgia.pptxTrigeminal Neuralgia.pptx
Trigeminal Neuralgia.pptxDr. Rahul Jain
 
Trigeminalneuralgiaseminar2 180526065218-converted
Trigeminalneuralgiaseminar2 180526065218-convertedTrigeminalneuralgiaseminar2 180526065218-converted
Trigeminalneuralgiaseminar2 180526065218-converteddrpankajyadav5
 
Trigeminal neuralgia
Trigeminal neuralgiaTrigeminal neuralgia
Trigeminal neuralgiaAlappatt Viji
 
Trigeminal neuralgia
Trigeminal neuralgiaTrigeminal neuralgia
Trigeminal neuralgiayury
 
Oncological emergencies - 2014
Oncological emergencies - 2014Oncological emergencies - 2014
Oncological emergencies - 2014Dr.T.Sujit :-)
 
Trigeminal Neuralgia
Trigeminal NeuralgiaTrigeminal Neuralgia
Trigeminal Neuralgiashabeel pn
 
Multiple sclerosis
Multiple sclerosisMultiple sclerosis
Multiple sclerosisManzar Ally
 
Trigeminal neuralgia in OMFS
Trigeminal neuralgia in OMFSTrigeminal neuralgia in OMFS
Trigeminal neuralgia in OMFSDr Rayan Malick
 
Trigeminal neuralgia By Meera R
Trigeminal neuralgia By Meera RTrigeminal neuralgia By Meera R
Trigeminal neuralgia By Meera Rmymove
 
Trigeminal neuralgia
Trigeminal neuralgiaTrigeminal neuralgia
Trigeminal neuralgiaAmr Hassan
 
Trigeminal Neuralgia Headache and CSF Hypotension and Hypertension(Pseudotumor)
Trigeminal Neuralgia Headache and CSF Hypotension and Hypertension(Pseudotumor)Trigeminal Neuralgia Headache and CSF Hypotension and Hypertension(Pseudotumor)
Trigeminal Neuralgia Headache and CSF Hypotension and Hypertension(Pseudotumor)Monique Canonico
 
Trigeminal Neuralgia
Trigeminal NeuralgiaTrigeminal Neuralgia
Trigeminal NeuralgiaFakhrul Imam
 
Posterior reversible encephalopathy syndrome
Posterior reversible encephalopathy syndromePosterior reversible encephalopathy syndrome
Posterior reversible encephalopathy syndromeNeurologyKota
 
Trigeminal neuralgia - Dr Sanjana Ravindra
Trigeminal neuralgia - Dr Sanjana RavindraTrigeminal neuralgia - Dr Sanjana Ravindra
Trigeminal neuralgia - Dr Sanjana RavindraDr. Sanjana Ravindra
 
Trigeminal neuralgia
Trigeminal neuralgiaTrigeminal neuralgia
Trigeminal neuralgiaAJAL A J
 

Similaire à Trigeminal neuralgia (20)

Trigeminal Neuralgia.pptx
Trigeminal Neuralgia.pptxTrigeminal Neuralgia.pptx
Trigeminal Neuralgia.pptx
 
Trigeminalneuralgiaseminar2 180526065218-converted
Trigeminalneuralgiaseminar2 180526065218-convertedTrigeminalneuralgiaseminar2 180526065218-converted
Trigeminalneuralgiaseminar2 180526065218-converted
 
Trigeminal neuralgia
Trigeminal neuralgiaTrigeminal neuralgia
Trigeminal neuralgia
 
Trigeminal neuralgia
Trigeminal neuralgiaTrigeminal neuralgia
Trigeminal neuralgia
 
Trigeminal
TrigeminalTrigeminal
Trigeminal
 
Oncological emergencies - 2014
Oncological emergencies - 2014Oncological emergencies - 2014
Oncological emergencies - 2014
 
Trigeminal Neuralgia
Trigeminal NeuralgiaTrigeminal Neuralgia
Trigeminal Neuralgia
 
Multiple sclerosis
Multiple sclerosisMultiple sclerosis
Multiple sclerosis
 
Trigeminal neuralgia in OMFS
Trigeminal neuralgia in OMFSTrigeminal neuralgia in OMFS
Trigeminal neuralgia in OMFS
 
Trigeminal neuralgia By Meera R
Trigeminal neuralgia By Meera RTrigeminal neuralgia By Meera R
Trigeminal neuralgia By Meera R
 
Trigeminal neuralgia
Trigeminal neuralgiaTrigeminal neuralgia
Trigeminal neuralgia
 
Diseases of Nerves
Diseases of NervesDiseases of Nerves
Diseases of Nerves
 
Trigeminal Neuralgia Headache and CSF Hypotension and Hypertension(Pseudotumor)
Trigeminal Neuralgia Headache and CSF Hypotension and Hypertension(Pseudotumor)Trigeminal Neuralgia Headache and CSF Hypotension and Hypertension(Pseudotumor)
Trigeminal Neuralgia Headache and CSF Hypotension and Hypertension(Pseudotumor)
 
Tb meningitis
Tb meningitisTb meningitis
Tb meningitis
 
Trigeminal Neuralgia
Trigeminal NeuralgiaTrigeminal Neuralgia
Trigeminal Neuralgia
 
Posterior reversible encephalopathy syndrome
Posterior reversible encephalopathy syndromePosterior reversible encephalopathy syndrome
Posterior reversible encephalopathy syndrome
 
Trigeminal neuralgia - Dr Sanjana Ravindra
Trigeminal neuralgia - Dr Sanjana RavindraTrigeminal neuralgia - Dr Sanjana Ravindra
Trigeminal neuralgia - Dr Sanjana Ravindra
 
Trigeminal neuralgia
Trigeminal neuralgiaTrigeminal neuralgia
Trigeminal neuralgia
 
Trigeminal neuralgia
Trigeminal neuralgiaTrigeminal neuralgia
Trigeminal neuralgia
 
trigeminal neuralgia
trigeminal neuralgiatrigeminal neuralgia
trigeminal neuralgia
 

Plus de Dr. Shahnawaz Alam

Decompressive Craniectomy.pptx
Decompressive Craniectomy.pptxDecompressive Craniectomy.pptx
Decompressive Craniectomy.pptxDr. Shahnawaz Alam
 
natural history surgical decision aneurysm.pptx
natural history surgical decision aneurysm.pptxnatural history surgical decision aneurysm.pptx
natural history surgical decision aneurysm.pptxDr. Shahnawaz Alam
 
SURGICAL PINEAL REGION TUMORS.pptx
SURGICAL PINEAL REGION TUMORS.pptxSURGICAL PINEAL REGION TUMORS.pptx
SURGICAL PINEAL REGION TUMORS.pptxDr. Shahnawaz Alam
 
Management of Peripheral Nerve Entrapment (Carpal Tunnel Syndrome).pptx
Management of Peripheral Nerve Entrapment  (Carpal Tunnel Syndrome).pptxManagement of Peripheral Nerve Entrapment  (Carpal Tunnel Syndrome).pptx
Management of Peripheral Nerve Entrapment (Carpal Tunnel Syndrome).pptxDr. Shahnawaz Alam
 
Imaging Cervico-vertebral junction: AAD with BI .pptx
Imaging Cervico-vertebral junction: AAD with BI .pptxImaging Cervico-vertebral junction: AAD with BI .pptx
Imaging Cervico-vertebral junction: AAD with BI .pptxDr. Shahnawaz Alam
 
Vertebrobasal Dolichoectesia.pptx
Vertebrobasal Dolichoectesia.pptxVertebrobasal Dolichoectesia.pptx
Vertebrobasal Dolichoectesia.pptxDr. Shahnawaz Alam
 
evaluation for epilepsy surgery.pptx
evaluation for epilepsy surgery.pptxevaluation for epilepsy surgery.pptx
evaluation for epilepsy surgery.pptxDr. Shahnawaz Alam
 
classification, pathophysiology and surgical management MOYAMOYA.pptx
classification, pathophysiology and surgical management  MOYAMOYA.pptxclassification, pathophysiology and surgical management  MOYAMOYA.pptx
classification, pathophysiology and surgical management MOYAMOYA.pptxDr. Shahnawaz Alam
 
APPROACH TO PETROCLIVAL MENINGIOMA
APPROACH TO PETROCLIVAL MENINGIOMAAPPROACH TO PETROCLIVAL MENINGIOMA
APPROACH TO PETROCLIVAL MENINGIOMADr. Shahnawaz Alam
 

Plus de Dr. Shahnawaz Alam (20)

DBS Advances.pptx
DBS Advances.pptxDBS Advances.pptx
DBS Advances.pptx
 
HIFU & LITT.pptx
HIFU & LITT.pptxHIFU & LITT.pptx
HIFU & LITT.pptx
 
peripheral nerve tumors.pptx
peripheral nerve tumors.pptxperipheral nerve tumors.pptx
peripheral nerve tumors.pptx
 
cerebral metastasis
cerebral metastasiscerebral metastasis
cerebral metastasis
 
Decompressive Craniectomy.pptx
Decompressive Craniectomy.pptxDecompressive Craniectomy.pptx
Decompressive Craniectomy.pptx
 
Intraventricular tumors.pptx
Intraventricular tumors.pptxIntraventricular tumors.pptx
Intraventricular tumors.pptx
 
natural history surgical decision aneurysm.pptx
natural history surgical decision aneurysm.pptxnatural history surgical decision aneurysm.pptx
natural history surgical decision aneurysm.pptx
 
endospine easygo system.pptx
endospine easygo system.pptxendospine easygo system.pptx
endospine easygo system.pptx
 
Traumatic brain injury.pptx
Traumatic brain injury.pptxTraumatic brain injury.pptx
Traumatic brain injury.pptx
 
SURGICAL PINEAL REGION TUMORS.pptx
SURGICAL PINEAL REGION TUMORS.pptxSURGICAL PINEAL REGION TUMORS.pptx
SURGICAL PINEAL REGION TUMORS.pptx
 
NRC intraventricular sol.pptx
NRC intraventricular sol.pptxNRC intraventricular sol.pptx
NRC intraventricular sol.pptx
 
Management of Peripheral Nerve Entrapment (Carpal Tunnel Syndrome).pptx
Management of Peripheral Nerve Entrapment  (Carpal Tunnel Syndrome).pptxManagement of Peripheral Nerve Entrapment  (Carpal Tunnel Syndrome).pptx
Management of Peripheral Nerve Entrapment (Carpal Tunnel Syndrome).pptx
 
Imaging Cervico-vertebral junction: AAD with BI .pptx
Imaging Cervico-vertebral junction: AAD with BI .pptxImaging Cervico-vertebral junction: AAD with BI .pptx
Imaging Cervico-vertebral junction: AAD with BI .pptx
 
Psychosurgery .pptx
Psychosurgery .pptxPsychosurgery .pptx
Psychosurgery .pptx
 
INSULAR GLIOMA SURGERY.pptx
INSULAR GLIOMA SURGERY.pptxINSULAR GLIOMA SURGERY.pptx
INSULAR GLIOMA SURGERY.pptx
 
Vertebrobasal Dolichoectesia.pptx
Vertebrobasal Dolichoectesia.pptxVertebrobasal Dolichoectesia.pptx
Vertebrobasal Dolichoectesia.pptx
 
evaluation for epilepsy surgery.pptx
evaluation for epilepsy surgery.pptxevaluation for epilepsy surgery.pptx
evaluation for epilepsy surgery.pptx
 
classification, pathophysiology and surgical management MOYAMOYA.pptx
classification, pathophysiology and surgical management  MOYAMOYA.pptxclassification, pathophysiology and surgical management  MOYAMOYA.pptx
classification, pathophysiology and surgical management MOYAMOYA.pptx
 
TRAUMATIC CCF
TRAUMATIC CCFTRAUMATIC CCF
TRAUMATIC CCF
 
APPROACH TO PETROCLIVAL MENINGIOMA
APPROACH TO PETROCLIVAL MENINGIOMAAPPROACH TO PETROCLIVAL MENINGIOMA
APPROACH TO PETROCLIVAL MENINGIOMA
 

Dernier

Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 

Dernier (20)

Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 

Trigeminal neuralgia

  • 1. Dr. Shahnawaz Alam Resident; MCh- Neurosurgery Moderated by: Dr. V. C. Jha HOD, Dept. of Neurosurgery TRIGEMINAL NEURALGIA DEFINITION, DDX, MANAGEMENT, SURGERY AND GKRS
  • 2. INTRODUCTION • Recurrent brief episodes of unilateral electric shock like pains, abrupt in onset and termination, in the distribution of one or more divisions of the trigeminal nerve that are typically triggered by innocuous stimuli. • Incidence: 40-50 cases per million; Prevalence: 100-200 cases per million (1) • Age group: 35-65 years (2); Right side more commonly affected; Gender: twice as common in females • Hereditary forms of TGN rare (<5%); B/l TGN have higher hereditary predisposition {1} 1. Manzoni G, Torelli P. Epidemiology of typical and atypical craniofacial neuralgias. Neurological Sciences. 2005;26(S2):s65-s67. {2} Koopman J, Dieleman J, Huygen F, de Mos M, Martin C, Sturkenboom M. Incidence of facial pain in the general population. Pain. 2009;147(1):122-127.
  • 3. Diagnosis of typical trigeminal neuralgia: five criteria 1. paroxysmal sharp and shooting pain that is characterized by exacerbations and remissions, 2. pain that follows the distribution of the trigeminal nerve, 3. a normal neurologic examination that includes no significant loss of facial sensation, 4. Magnetic resonance imaging (MRI) of the brain that demonstrates neither mass lesions nor demyelinating plaques, and 5. pain that is induced by cutaneous stimulation.
  • 4. BRIEF HISTORY • First scientific account: Johannes Laurentius Bausch (1671) • Synonyms: Suicide disease, Prosopalgia , Tic Douloureux, Fothergill’s Disease • 1820 Charles Bell coined Trigeminal Neuralgia • 1904  Percutaneous alcohol injection by Schloesser • 1920  Spiller-Frazier technique of selective sectioning of Trigeminal nerve fibres, Walter Dandy: ‘arterial loop impingement’ • 1940  Bergouinan used antiepileptic in TGN • 1970 Leksell used stereotactic radiation • 1996 Peter Janetta: MVD
  • 5. DEFINITION (ICHD-3, 2018,IHS) • Recurrent paroxysms of unilateral facial pain in the distribution(s) of one or more divisions of the trigeminal nerve, with no radiation beyond, and fulfilling criteria B and C • A  All the pain characteristics: • lasting from a fraction of a second to 2 minutes • severe intensity • electric shock-like, shooting, stabbing or sharp in quality • B Precipitated by innocuous stimuli • C Not better accounted for by another ICHD-3 diagnosis.
  • 6. CLINICAL FEATURES • Pain may radiate to another division; Identification of Trigger • Usually fail to show sensory abnormalities • In severe cases can evoke contraction of the facial muscles of the affected side • Mild autonomic symptoms like lacrimation or redness of eye may be present • Refractory period TYPES: a) Classical Type b) Secondary Type c) Idiopathic Type
  • 7. CLASSICAL TGN • Classical TGN: Demonstration on MRI/Surgery of Neurovascular Compression and morphological changes 1) Classical TGN: Purely Paroxysmal pain free between attacks 2) Atypical TGN/Type II TGN: Concomitant continuous pain between attacks; Atypical- aching, throbbing, burning, >50% constant pain.
  • 8. • Morphological changes: Nerve root atrophy (demyelination, neuronal loss, microvasculature changes)/ displacement. • Compression by artery more symptomatic than by compression of vein.
  • 9. SECONDARY TGN • Secondary TGN : An underlying disease known to cause neuralgia 1)TGN attributed to MS 2)TGN attributed to SOL 3)TGN attributed to other casues IDIOPATHIC TGN • Idiopathic TGN: MRI or electrophysiologic testing showing no abnormalities • IASP definition: “unilateral painful orofacial condition characterized by brief duration of electric shock-like sensation with an abrupt onset and termination, and limited to one or more sensory divisions of the trigeminal nerve”
  • 11. DIRECT COMPRESSION OF TRIGEMINAL NERVE • Neurovascular Compression : (80-90% cases) Vascular Loop; SCA(85%)> AICA > PICA > VA Venous loop • MC site: Dorsal Root Entry Zone near Pons Laminar Arrangement of fibres in Trigeminal nerve (Medial V2 ,Lateral/caudal V3 , rarely Cranial  V1 symptoms) • Tumours(2%) : Meningioma/Vestibular Schwannoma/epidermoid/Tuberculoma/Arachnoid Cyst {Tumours at REZ cause neuralgia, peripheral compression causes more constant pain} • AVM/Aneurysms
  • 12. SYSTEMIC DISEASES • Multiple Sclerosis In 0.9-4.5% patients of MS; young, Bilateral presentation MR: demyelinating lesion at pontine REZ • Vascular diseases, Rheumatism, Diabetes, HTN no proven role • TGN association with atherosclerosis/Arterial hypertonia • Following previous surgery; Allergic Hypothesis • TM joint pathology, high position of petrous apex, acute bony angle of petrous ridge, short trigeminal nerve cisternal length.
  • 13. PATHOPHYSIOLOGY • REZ/Redlich-Obersteiner’s Zone: boundary b/w CNS and PNS junction between myelin of Schwann and glial cells • Visually identified as 1-2.5 mm Zone; Thin A delta nociceptive fibres are highly susceptible to pressure • Long standing compression: membrane instability and demyelination interconnection between neurones • Nerve deviation/distortion: groove formation nerve atrophy {Atrophic changes in proportion to severity of compression}
  • 14. PATHOGENESIS • Short Connection Theory: demyelination and cross talk (Pressure on highly susceptible A delta fibres; ectopic impulse generation; abnormal non synaptic transmission. • Ignition Hypothesis: Trigeminal root ganglia neuronal abnormalities hyperexcitability of neurones and synchronous firing • Pulsatile mechanical compression by vessel • Cutaneous stimuli stimulate pain fibres which are in close proximity at REZ • Focal demyelination not always present • Central Pathogenetic Mechanism
  • 15. DIFFERENTIAL DIAGNOSIS • Deafferentation pain: post surgical injury/trauma {constant itching or burning pain , sensory loss} • Dental causes: caries, abscess, periodontitits, cracked tooth unilateral and localised pain, usually constant, oral mucosal examination for causes. • Temporo-Mandibular Joint Disorders  restricted mouth opening or cracking noises. on prolonged mouth opening, palpation of joint and local examination • Salivary Gland Disorders  obstruction of flow of saliva :intermittent pain(tumors, stones) ; infection • Maxillary sinusitis Acute sinusitis, nasal discharge,tenderness, dull mild to moderate pain
  • 16. TRIGEMINAL AUTONOMIC CEPHALALGIAS • Primary headache disorders with cranial autonomic symptoms and pain in Trigeminal nerve distribution. • Cluster Headache, Paroxysmal Hemicranias, SUNCT, SUNA • Cluster headache: temporal association with sleep (episodic, u/l typically periorbital, prolonged course of 15-180 mins, severe throbbing type, conjunctival injection). • SUNCT/SUNA : paroxysmal ocular or periocular pain with ipsilateral autonomic symptoms intense: Conjunctival injection, lacrimation, nasal congestion, rhinorrhoea, sweating and flushing of forehead • More common in V1 and least in V3
  • 17. Difference between TGN and SUNCT/SUNA
  • 18. DIFFERENTIAL DIAGNOSES • Post-Herpetic Neuralgia : Usually months after resolution of Herpes Zoster; Dermatomal Vesicopapular Rash; Allodynia, burning sharp pain; Sensory loss to pinprick, temperature in affected areas; Continuous pain with fluctuating severity • Glossopharyngeal neuralgia: pain in throat- ear areas inferior to angle of mandible, precipitated by swallowing, chewing • Nervus Intermedius neuralgia - brief paroxysmal pain in ear canal • Hemifacial spasm/ Tolosa Hunt syndrome/ Migraine • Perineural spread of head and neck malignancies
  • 19. RED FLAG SIGNS IN CLINICAL EXAMINATION FOR SECONDARY AETIOLOGIES  Sensory or motor deficits in cranial nerve examination  Abnormal oral, dental, or ear examination  Age younger than 40 years  Presence of bilateral symptoms  Dizziness or vertigo  Hearing loss or abnormality  Pain episodes persisting longer than two minutes  Pain outside of trigeminal nerve distribution  Severe Autonomic symptoms
  • 20. MRI • Obersteiner Redlich zone: 1mm for motor root and 3 mm for sensory root • Visual inspection: thinning of trigeminal myelin sheath • Ventrolateral pons: two different roots • Gasserian ganglion
  • 22. CLINICAL DIAGNOSIS OF TGN PHARMACOLOGIC THERAPY WITH CBZ/OXZ DOSE ESCALATION AND ADDITION OF 2nd/3rd LINE DRUGS PHARMACORESISTANT TGN MRI AND OTHER SIGNS NERUOVASCULAR CONFLICT + ASA I OR AGE < 75 yrs MVD ASA II OR AGE > 75yrs NEUROVASCULAR CONFLICT - SRS, PERCUTANEOUS PROCEDURES, NEUROMODULATIVE PROCEDURES SECONDARY CAUSES UNDERLYING CAUSE TREATMENT
  • 24. PHARMACOTHERAPY • First line: CARBAMAZEPINE (Level A evidence) DOSE: 100 to 200 mg twice daily and increase in 200 mg daily dose as tolerated upto 600-800 mg daily and maximum of 1200 mg daily; Sodium channel blockade and membrane stabilisation; Efficacy: 80% pain relief • HLA-B 1502 individuals higher incidence of Steven Johnson syndrome and TEN, CBC, Sodium and LFT monitoring; CYP 450 system and failure of OCPs; 6 to 10% patients are unable to tolerate. • Oxcarbamazepine: Similar efficacy to CBZ; Pro-drug; Better Tolerability and fewer drug interactions; Weak enzyme inducer; Dose: 150 mg BD  increased 300 mg every 3 days to 300-600mg and maximum of 1800 mg. • 2nd line Drugs :Lamotrigine, Baclofen, Pimozide
  • 25. SECOND LINE DRUGS • LAMOTRIGINE: Superior to placebo in CBZ refractory cases; starting dose at 25 mg/day to 200-400 mg/day gradually; slower titration gives slower occurance of side effects. • BACLOFEN : GABAb receptor antagomist; dose of 5-10mg TDS and increased slowly upto a maximum; dose of 90mg per day; Renal excreted drug • Pimozide :Extrapyramidal side effects; Gabapentin, Pregabalin  moderate efficacy. • Phenytoin(60% pain relief); Topiramate(75% pain relief); Levetiracetam(50% pain relief); TCA: No role in TGN; Quality of evidence poor. • ACUTE EXACERBATION TREATMENT: initially used local anasthetic and iv lidocaine; Insufficient evidence and not recommended; Treatment duration: No definitive evidence of duration of treatment to conclude failure of first line drugs and indication for surgery
  • 26. SURGICAL MODALITIES • Percutaneous: Glycerol Retrogasserian Rhizolysis; Radiofrequency Thermocoagulation; Percutaneous Microballon Compression. • Invasive surgery: Microvascular Decompression; Partial sensory Rhizotomy; Internal Neurolysis; Cryotherapy • Ablative vs Nonablative procedures.
  • 31. When to refer for Surgery? No specific conclusion; 70% patients who failed primary therapy wished earlier surgery Failure of first line therapy; ? Second line therapy Age(old and young) and life expectancy(<20yrs) Anaesthetic fitness for Surgery; Severity of the Pain Which Surgical Procedure to choose? MVD has higher and longer duration of pain control; MVD has 90 % pain control immediately and 73% at 5 years; Lower chance of hypoesthesia Peripheral Local anaesthetic techniques not effective. Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K et al. Practice Parameter: The diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 2008;71(15):1183-1190
  • 32. MICROVASCULAR DECOMPRESSION • Long term success rate of 89-100%; More effective in classical TGN with only paroxysmal attacks • Acute pain relief in 91% and recurrence of 18%; Initial outcome better than GKRS. • Better at initial response and lower recurrence rate than partial sensory rhizotomy • MVD and PBC has similar initial pain control but MVD has lower recurrence rate.
  • 33. MICROVASCULAR DECOMPRESSION • Supine position, head rotated and fixed to opposite side, lateral decubitus position • Linear retromastoid incision of approx. 3- 5 cm with a fourth above the iniomeatal line • Retromastoid Craniotomy made starting at inferior and posterior to the transverse - sigmoid junction • Supralateral Cerebellar approach  Dura opened in inverted L or C shaped fashion; CSF drained by gentle retraction of the cerebellum.  Retraction of cerebellum in Inferomedial direction gently just below petro-tentorial junction (pure medial retraction = more injury to CN VIII).  Exposure of Superior petrosal vein and arachnoid membrane just inferior to this vessel dissected; Superior petrosal venous bleed coagulated close to cerebellum.
  • 36. • Correct Identification of cranial nerves: 7th and 8th complex runs superficially, obliquely • 5th nerve more medially and deeper; Careful arachnoid dissection with preservation of BS vessels • Exposure of Trigeminal nerve REZ. NEUROVASCULAR CONFLICTS  Most common by SCA or its branches along the superior shoulder f REZ  Combined compression between SCA and AICA; Between Trigeminal and petrosal veins; By superior Petrosal vein.
  • 37.  Decompression requires elevating the SCA upward and away from the nerve; Arterial loops dissected along the length of the nerve; Multiple Vascular loops.  Implant: Shredded Teflon; Placed at REZ and pushed ahead parallel to the nerve; Unshredded Teflon: more chance of displacement; Materials: Teflon(Polytetrafluoroethylene), Ivalon(Polyvinyl acetal).  Partial sensory root sectioning is indicated in negative vessel explorations during surgery and large intraneural vein.  Complications • MC complication is aseptic meningitis(11%); Cranial nerve damage, Transient conductive hearing loss. • SNHL major long term complication (prevented by gentle retraction and prevention of AICA vasospasm) • Prolonged post-operative vertigo /tinnitus; CSF rhinorrhoea(4%); Cerebellar contusions.
  • 38. GKRS • First used by Dr Leksell in 1971; Procedure: Leksell stereotactic head frame  MRI(T1w with or without contrast and T2 CISS sequences)Treatment planning GKRS. • Single shot, 4 mm beam collimator diameter; Dose: 70-90 Gy.; Higher dose associated with higher post irradiation complications but better rates of improvement and lesser recurrence; Higher required doses placed isocentre anteriorly on TGN away from brainstem Target Selection: Options: 1. REZ close to Brainstem(Pollock et al 90% pain control) 2. Marseille point(distal most portion of cisternal CN V close to Meckels cave) (Regis et al. 87% pain control) 3. Gasserian ganglion anteriorly(Messenger et al higher sensory complications) • Pain relief better if isocentre located close to REZ; Less complications if target placed anteriorly; Anterior targets are likely to have same initial pain control.
  • 39. AGasserian gangliona; B  Marseille point; C REZ; D Dual Centre
  • 40. • Gradual response Time to response after GKRS better in anterior retrogasserian target(median -4.1 weeks) vs REZ targets(median – 6.4 weeks). • Median latency to symptom improvement- 2 months; Need some medications(although reduced dosage). • Freedom from pain with medication(84.8%) vs without medication(53.1%); Long Term outcome: Good pain control of 45-65% by 5 years. • Abnormal vessel: Doesn’t alter outcome. • Redo GKRS: Can be done in patients with an earlier good response to GKRS; Primary GKRS > Secondary GKRS(in pain relief) • Pain in V1: GKRS safest option as corneal hyposthesia never occur; No Radioprotectant role of CBZ/OXZ; Treatment failure if no symptomatic improvement by 180 days. • Outcome: 75-90% patients had pain relief after 1 year of GKRS.
  • 41. Predictors of good pain control: • Type of Pain at presentation, post GK BNI score, Post GK facial numbness (major predictor of maintenance of pain relief). • Patients with early response within 3 weeks had longer duration of complete free pain. • Length of Cisternal segment of Trigeminal nerve; Target on Trigeminal nerve 5-8 mm away from brainstem Favourable outcomes: • young patient, length of trigeminal nerve irradiated, higher dose of radiation, proximity of isocentre to Brainstem.
  • 42. Stereotactic RS yields better response if done within 3 years of symptom onset. Poor prognosticator factors: atypical facial pain and presence of MS  Recurrence rate of TGN post GKRS is 23% at approximately 8 to 20 months Side effects: facial numbness(more in anterior target or longer length of nerve irradiated or higher doses),parenchymal injuries, vascular injuries.
  • 43. References: • Youmans and Winn neurological surgery 8th edition • Ramamurthi & Tandon's textbook of neurosurgery 3rd edition • Schmidek and Sweet: Operative Neurosurgical Techniques 6th edition • Internet THANK YOU